188 related articles for article (PubMed ID: 32216707)
1. Development of Novel Radiosensitizers through the National Cancer Institute's Small Business Innovation Research Program.
Zakeri K; Narayanan D; Prasanna PGS; Vikram B; Buchsbaum JC
Radiat Res; 2020 May; 193(5):425-434. PubMed ID: 32216707
[TBL] [Abstract][Full Text] [Related]
2. Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.
Zakeri K; Narayanan D; Vikram B; Evans G; Coleman CN; Prasanna PGS
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):188-196. PubMed ID: 30583040
[TBL] [Abstract][Full Text] [Related]
3. Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research Pathway.
Zakeri K; Narayanan D; Evans G; Prasanna P; Buchsbaum JC; Vikram B; Capala J
J Nucl Med; 2019 Jan; 60(1):41-49. PubMed ID: 30030338
[TBL] [Abstract][Full Text] [Related]
4. Investor initiatives program: Public-private partnerships to expedite commercialization for NCI-funded small business entrepreneurs.
Connors B; Lou XJ; Subedee A; Zhang K; Weingarten M; Narayanan D
Clin Transl Sci; 2021 Nov; 14(6):2124-2131. PubMed ID: 34387931
[TBL] [Abstract][Full Text] [Related]
5. CARE program: NCI and FDA interagency collaborations to support oncology small business entrepreneurs.
Pond MA; Narayanan D; Zhang K; Fau D; Summers J; Carranza D; Weingarten M
Clin Transl Sci; 2023 Mar; 16(3):412-421. PubMed ID: 36601678
[TBL] [Abstract][Full Text] [Related]
6. Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.
Prasanna PG; Narayanan D; Hallett K; Bernhard EJ; Ahmed MM; Evans G; Vikram B; Weingarten M; Coleman CN
Radiat Res; 2015 Sep; 184(3):235-48. PubMed ID: 26284423
[TBL] [Abstract][Full Text] [Related]
7. National Cancer Institute support for targeted alpha-emitter therapy.
Hong JA; Brechbiel M; Buchsbaum J; Canaria CA; Coleman CN; Escorcia FE; Espey M; Kunos C; Lin F; Narayanan D; Capala J
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):64-72. PubMed ID: 34378064
[TBL] [Abstract][Full Text] [Related]
8. National Institute on Aging seed funding enables Alzheimer's disease startups to reach key value inflection points.
Ghazarian AL; Haim T; Sauma S; Katiyar P
Alzheimers Dement; 2022 Feb; 18(2):348-359. PubMed ID: 34374496
[TBL] [Abstract][Full Text] [Related]
9. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
George TJ; Franke AJ; Chakravarthy AB; Das P; Dasari A; El-Rayes BF; Hong TS; Kinsella TJ; Landry JC; Lee JJ; Monjazeb AM; Jacobs SA; Raben D; Rahma OE; Williams TM; Wu C; Coleman CN; Vikram B; Ahmed MM
Cancer; 2019 Aug; 125(16):2732-2746. PubMed ID: 31017664
[TBL] [Abstract][Full Text] [Related]
10. Geographically-related outcomes of U.S. funding for small business research and development: Results of the research grant programs of a component of the National Institutes of Health.
Onken J; Aragon R; Calcagno AM
Eval Program Plann; 2019 Dec; 77():101696. PubMed ID: 31404866
[TBL] [Abstract][Full Text] [Related]
11. Creative partnerships for funding nursing research.
McCann JJ; Hills EB; Zauszniewski JA; Smith CE; Farran CJ; Wilkie DJ
West J Nurs Res; 2011 Feb; 33(1):79-105. PubMed ID: 20719996
[TBL] [Abstract][Full Text] [Related]
12. Using database linkages to measure innovation, commercialization, and survival of small businesses.
Onken J; Miklos AC; Dorsey TF; Aragon R; Calcagno AM
Eval Program Plann; 2019 Dec; 77():101710. PubMed ID: 31518846
[TBL] [Abstract][Full Text] [Related]
13. NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P; Coleman CN; Dicker AP
J Natl Cancer Inst; 2013 Jan; 105(1):11-24. PubMed ID: 23231975
[TBL] [Abstract][Full Text] [Related]
14. Specialized Smartphone Intervention Apps: Review of 2014 to 2018 NIH Funded Grants.
Hansen WB; Scheier LM
JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14655. PubMed ID: 31359866
[TBL] [Abstract][Full Text] [Related]
15. Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?
Prasanna PGS; Narayanan D; Zhang K; Rahbar A; Coleman CN; Vikram B
Radiat Res; 2020 Mar; 193(3):199-208. PubMed ID: 31910120
[TBL] [Abstract][Full Text] [Related]
16. Fostering Diversity and Inclusion in the National Heart, Lung, and Blood Institute's Small Business Program.
Padmore EW; McMahon MJ
Ethn Dis; 2019; 29(Suppl 1):71-76. PubMed ID: 30906152
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio.
Yu JB; Beck TF; Anscher MS; Baschnagel AM; Brock KK; Carlson DJ; Dominello MM; Kimple RJ; Knisely JP; Mendonca MS; Mian OY; Singh AK; Moros EG; Keen JC
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):297-304. PubMed ID: 30647006
[TBL] [Abstract][Full Text] [Related]
18. National Institutes of Health phase I, Small Business Innovation Research applications: fiscal year 1983 results.
Vener KJ
Fed Proc; 1985 Aug; 44(11):2679-84. PubMed ID: 4018273
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
